Continuous Glucose Monitor System Market Report 2026

Continuous Glucose Monitor System Market Overview

• Continuous Glucose Monitor System market size has reached to $9.6 billion in 2025 • Expected to grow to $19.18 billion in 2030 at a compound annual growth rate (CAGR) of 14.8% • Growth Driver: Rising Diabetes Prevalence Fuels Growth Of The Market • Market Trend: Expanding Access To Over-The-Counter Continuous Glucose Monitors For Health Management • North America was the largest region in 2025.

What Is Covered Under Continuous Glucose Monitor System Market?

A continuous glucose monitoring (CGM) system is a medical device designed for individuals with diabetes to continuously track their glucose levels in real time. The system usually includes a small sensor inserted under the skin that measures glucose levels in the interstitial fluid, transmitting this data to a receiver or smartphone app for easy monitoring. This technology helps users make informed decisions about insulin dosing and lifestyle choices to manage their blood sugar effectively. The main types of continuous glucose monitor system components are transmitters, receivers, and sensors. Transmitters are devices that convert a signal into a form suitable for transmission, often used to send data over distances. It comes with technology such as real-time continuous glucose monitoring and intermittently scanned continuous glucose monitoring for various demographics, including child populations and adult populations. It is used for several applications, such as type-1 diabetes, type-2 diabetes, and gestational diabetes, and is used by various end users, including diagnostics centers, hospitals, clinics, intensive care units (ICUs), and home healthcare.

What Is The Continuous Glucose Monitor System Market Growth Forecast?

The continuous glucose monitor system market size is expected to see rapid growth in the next few years. It will grow to $19.18 billion in 2030 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to increasing adoption of closed-loop insulin delivery systems, rising demand for remote patient monitoring, expansion of personalized diabetes management solutions, growing integration with digital health platforms, increasing focus on non-invasive glucose sensing. Major trends in the forecast period include increasing adoption of smartphone-integrated cgm systems, rising use of real-time glucose monitoring solutions, growing integration of ai-based glucose analytics, expansion of wearable sensor technologies, enhanced focus on continuous patient monitoring.

Global Continuous Glucose Monitor System Market Segmentation

1) By Component: Transmitters, Receivers, Sensor 2) By Technology: Real Time Continuous Glucose Monitoring, Intermittently Scanned Continuous Glucose Monitoring 3) By Demography: Child Population, Adult Population 4) By Application: Type-1 Diabetes, Type-2 Diabetes, Gestational Diabetes 5) By End-User: Diagnostics Centers, Hospitals, Clinics, Intensive Care Unit (ICUs), Home Healthcare Subsegments: 1) By Transmitters: Bluetooth-Enabled Transmitters, Wireless Transmitters 2) By Receivers: Dedicated Devices (CGM Receiver), Smartphone-Based Receivers, Cloud-Connected Receivers 3) By Sensor: Enzyme-Based Sensors, Non-Enzyme-Based Sensors, Electrochemical Sensors

What Is The Driver Of The Continuous Glucose Monitor System Market?

The increasing prevalence of diabetes is expected to propel the growth of the continuous glucose monitor system market going forward. Diabetes is a chronic medical condition characterized by high blood sugar levels resulting from the body’s inability to produce or use insulin effectively. The rise in diabetes is primarily attributed to factors such as increasing rates of obesity, unhealthy diets, physical inactivity, and an aging population. Continuous glucose monitoring (CGM) systems provide real-time glucose readings, helping manage diabetes by detecting trends and alerting users to abnormal levels. They improve glycemic control while minimizing the need for frequent finger pricks. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents a significant increase compared to 3,065,825 in 2022, highlighting a rise of nearly 20%. Therefore, the increasing prevalence of diabetes is driving the growth of the continuous glucose monitor system industry.

Key Players In The Global Continuous Glucose Monitor System Market

Major companies operating in the continuous glucose monitor system market are Abbott Corporation, Medtronic PLC, Murata Manufacturing Co. Ltd., Dexcom Inc., Sinocare Inc., Tandem Diabetes Care Inc., Ascensia Diabetes Care Holdings AG, Glooko Inc., DarioHealth Corp., Menarini Diagnostics SRL, Senseonics Holdings Inc., WaveForm Technologies Inc., Medtrum Technologies Inc., Biolinq Incorporated, Ultrahuman Inc., GlySens Incorporated, Glucotrack, EOFLOW CO. LTD., Nemaura Medical Inc., Meiqi Medical Equipment, Nipro Diagnostics UK Limited

Global Continuous Glucose Monitor System Market Trends and Insights

Major companies operating in the continuous glucose monitor system market are focusing on developing advanced over-the-counter continuous glucose monitors (CGMs) to enhance accessibility and expand their reach among non-prescription users. An over-the-counter (OTC) continuous glucose monitor (CGM) is a device that tracks glucose levels in real-time without a prescription. It provides consumers with easy, convenient access to monitor their glucose independently. For instance, in September 2024, Abbott Laboratories, a US-based medical device company, launched Lingo in the United States. Designed for adults without diabetes, Lingo enables users to track glucose levels, offering valuable insights into the effects of diet and exercise on overall health. With a wearability of up to 14 days, this device supports Abbott's strategy to tap into the growing market of consumers focused on prediabetes management and wellness, all without the need for a prescription.

What Are Latest Mergers And Acquisitions In The Continuous Glucose Monitor System Market?

In August 2024, Abbott, a US-based manufacturer of continuous glucose monitors, partnered with Medtronic plc. to create an integrated continuous glucose monitoring (CGM) system. This collaboration seeks to improve diabetes management for millions of patients worldwide who rely on intensive insulin therapy. Medtronic plc is an Ireland-based medical device company that provides continuous glucose monitoring (CGM) systems.

Regional Outlook

North America was the largest region in the continuous glucose monitor (CGM) system market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Continuous Glucose Monitor System Market?

The continuous glucose monitor system market consists of revenues earned by entities by providing services such as data integration, personalized insights, and remote monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The continuous glucose monitor (CGM) system market also includes sales of sensors, transmitters, data management software, and receivers/display devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.